Janney Montgomery Scott
RXRX icon

Janney Montgomery Scott’s Recursion Pharmaceuticals RXRX Stock Holding History

Janney Montgomery Scott’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,100
Closed -$51K – 2962
2025
Q2 		$51K Buy
+10,100
New +$49.6K ﹤0.01% 2677
2024
Q2 		– Sell
-31,095
Closed -$310K – 2787
2024
Q1 		$310K Buy
+31,095
New +$346K ﹤0.01% 2319
2023
Q4 		– Sell
-15,270
Closed -$117K – 2739
2023
Q3 		$117K Buy
+15,270
New +$152K ﹤0.01% 2457

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott's RXRX Position: Q3 2025 in Review

Janney Montgomery Scott sold out of Recursion Pharmaceuticals (RXRX) in Q3 2025, closing a stake of 10,100 shares — an estimated $51K sold.

Janney Montgomery Scott first reported a position in RXRX in Q3 2023 and held it in 3 quarters. The position peaked at $310K in Q1 2024. 322 funds tracked by Wall St. Rank hold RXRX as of Q3 2025.

  • Janney Montgomery Scott reported no remaining Recursion Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,100 Recursion Pharmaceuticals shares in Q3 2025, an estimated $51K.
  • Janney Montgomery Scott first reported a position in Recursion Pharmaceuticals in Q3 2023 and held it in 3 quarters.
  • Janney Montgomery Scott's Recursion Pharmaceuticals position peaked at $310K in Q1 2024.
  • 322 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2025.

Based on Janney Montgomery Scott's 13F filing for Q3 2025, filed 27 Oct 2025.